US FDA Reports Facial Paralysis In 4 Volunteers For Pfizer’s Covid-19 Vaccine

Mumbai : A new report by the United States Food and Drug Administration (FDA) regulators revealed that four volunteers for the COVID-19 experimental vaccine by Pfizer developed Bell’s Palsy after receiving vaccine shots, as per media reports.

Bell’s palsy is a condition that causes a temporary paralysis of the muscles in the face. It can occur when the nerve that controls your facial muscles becomes inflamed, swollen, or compressed.

FDA added in its report that it is unclear what caused Bell’s Palsy in the four volunteers. According to media reports, the FDA regulators have asked health experts to continuously monitor volunteers who had participated in the trials of the Covid-19 vaccine.

Earlier, Pfizer CEO Albert Bourla seemed dubious about the efficacy of the vaccine. During his interview with NBC’s Lestor Holt, he said, “I think this is something that needs to be examined. We are not certain about that right now with what we know.”

This comes as many countries, especially rich nations, are competing with each other to secure Covid-19 vaccines for their population. According to previous reports, some countries, including Canada, the US, UK, among others, have secured Covid-19 vaccines that are enough to inoculate their entire population multiple times, leaving lower-middle countries in a dearth of it.

  • Related Posts

    Semaglutide generics ‘stimulating’ Obesity market growth, says Eli Lilly’s Patrik Jonsson

    New Delhi: The entry of semaglutide generics in India is ‘stimulating’ market growth and providing a favourable push to Eli Lilly’s blockbuster brand Mounjaro (tirzepatide), said Patrik Jonsson, Executive Vice…

    Pak-made illegal cosmetics recovered from Itwari shop

    Nagpur: Maharashtra Food and Drug Administration (FDA), Nagpur Division, raided a cosmetics firm in Itwari market and seized Pakistan-origin beauty products suspected to have harmful mercury and steroids last week. The…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Semaglutide generics ‘stimulating’ Obesity market growth, says Eli Lilly’s Patrik Jonsson

    Semaglutide generics ‘stimulating’ Obesity market growth, says Eli Lilly’s Patrik Jonsson

    Pak-made illegal cosmetics recovered from Itwari shop

    Pak-made illegal cosmetics recovered from Itwari shop

    Licences of 20 medical stores suspended after inspections

    Licences of 20 medical stores suspended after inspections

    Bain Capital sells nearly 1 pc stake in Emcure Pharma for Rs 289 crore

    Bain Capital sells nearly 1 pc  stake in Emcure Pharma for Rs 289 crore

    Sun Pharma to acquire U.S. firm Organon in $11.75 billion deal

    Sun Pharma to acquire U.S. firm Organon in $11.75 billion deal

    HP accounts for 47 inferior drugs in March alert

    HP accounts for 47 inferior drugs in March alert